Tandem Diabetes Care Inc
SWB:TD5A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tandem Diabetes Care Inc
SWB:TD5A
|
US |
|
California Resources Corp
F:1CLD
|
US |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
F:3S0
|
IT |
|
E
|
Exor NV
XBER:EYX
|
NL |
|
S
|
SLM Corp
DUS:SM1
|
US |
|
Monopar Therapeutics Inc
F:1IY
|
US |
|
Selective Insurance Group Inc
NASDAQ:SIGI
|
US |
|
AMN Healthcare Services Inc
NYSE:AMN
|
US |
|
O
|
Osaka Gas Co Ltd
F:OSA
|
JP |
|
8
|
8x8 Inc
XBER:EGT
|
US |
|
A
|
Amgen Inc
XBER:AMG
|
US |
|
PAMT Corp
NASDAQ:PAMT
|
US |
|
P
|
Petroleo Brasileiro SA Petrobras
SWB:PJX
|
BR |
Wall St Price Targets
TD5A Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for TD5A is 25.87 EUR with a low forecast of 14.91 EUR and a high forecast of 45.6 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TD5A's stock price target?
Price Target
25.87
EUR
According to Wall Street analysts, the average 1-year price target for TD5A is 25.87 EUR with a low forecast of 14.91 EUR and a high forecast of 45.6 EUR.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
14%
The compound annual growth rate for Gross Profit over the next 5 years is 14%.
